Surgery Partners, Inc. SGRY

14.40 0.20 1.41% as of 25 Sep
Market cap
$1.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 81.58
P/S ratio
0.59 0.86 1.45 0.95 1.74 0.76 0.41 0.27 0.48 0.65
P/FCF ratio
8.12 12.58 17.21 26.55 108.97 5.39 10.29 3.79 7.07 8.64
P/Operating CF
19.01 23.97 63.47 335.88 196.36 158.99 29.77 10.33 11.86 22.99
P/B ratio
0.63 0.84 1.31 0.82 1.96 1.60 0.77 0.43 0.48 2.29
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.64 1.85 2.39 1.87 2.88 2.13 1.77 1.47 1.98 1.85
EV/EBITDA
9.22 11.08 14.23 10.07 15.56 13.70 10.06 16.95 12.28 8.79
EV/Operating CF
19.79 19.23 22.30 29.96 73.68 16.01 25.05 18.07 22.00 16.90
EV/FCF
22.42 27.18 28.39 52.22 180.77 15.06 44.14 21.07 29.13 24.58
Quick Ratio
1.37 1.36 1.32 1.50 1.53 1.26 1.05 1.41 1.53 1.55
Current Ratio
1.87 1.79 1.71 1.87 1.76 1.44 1.32 1.68 1.86 1.94
Net Debt/EBITDA
5.88 5.95 5.60 4.95 6.18 8.80 7.71 13.90 9.30 5.70
Debt/Assets
45.60% 42.72% 40.36% 39.24% 48.04% 52.77% 51.42% 49.75% 47.36% 62.57%
Debt/Equity
1.18 1.05 0.91 0.89 1.49 2.17 1.87 1.60 1.31 4.44
Asset Turnover
0.41 0.42 0.40 0.40 0.39 0.36 0.38 0.38 0.39 0.52
Operating CF/Net income
(3.52) (1.79) (24.69) (2.91) (1.07) (1.59) (1.17) (0.61) (1.53) 13.25
Capex/Depreciation
(0.18) (0.58) (0.53) (0.59) (0.52) 0.16 (0.73) (0.31) (0.57) (0.99)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(2.46%) (5.40%) (0.40%) (2.22%) (5.69%) (16.68%) (10.61%) (19.55%) (9.52%) 3.04%
ROA
(0.97%) (2.28%) (0.18%) (0.85%) (1.41%) (2.98%) (2.28%) (5.12%) (2.28%) 0.43%
ROIC
3.69% 3.46% 3.65% 4.09% 4.18% 2.97% 3.81% 1.35% 2.69% 7.24%
Return on Tangible Assets
(4.61%) (10.62%) (0.89%) (4.19%) (7.82%) (19.71%) (16.98%) (35.79%) (12.01%) 2.49%
Average Days of Receivables
66.43 67.87 66.05 65.59 70.57 75.00 65.15 63.38 78.38 70.29
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
3.57% 4.45% 4.41% 4.02% 2.97% 2.74% 4.84% 5.28% 5.67% 5.26%
Intangible Assets out of Total Assets
0.64 0.65 0.64 0.63 0.65 0.65 0.69 0.74 0.74 0.70
Share Based Compensation of Revenue
0.45% 1.07% 0.65% 0.72% 0.78% 0.71% 0.56% 0.52% 0.42% 0.18%
Graham Net Nets
(1.95) (1.34) (0.74) (1.17) (0.83) (2.33) (4.12) (5.59) (3.71) (2.17)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.38
Earnings Yield
(4.01%) (6.28%) (0.32%) (2.21%) (2.32%) (10.96%) (14.50%) (50.66%) (12.28%) 1.23%
Free Cash Flow Yield
12.32% 7.95% 5.81% 3.77% 0.92% 18.55% 9.72% 26.37% 14.15% 11.57%
Revenue per Share
26.01 24.69 21.84 27.62 30.72 38.14 37.93 36.88 27.76 23.85
Operating CF per Share
2.16 2.38 2.34 1.73 1.20 5.06 2.68 3.01 2.50 2.61
Capex per Share
(0.25) (0.70) (0.50) (0.74) (0.71) 0.32 (1.16) (0.43) (0.61) (0.81)
Free Cash Flow per Share
1.90 1.68 1.84 0.99 0.49 5.38 1.52 2.58 1.89 1.79
Cash per Share
1.89 2.14 1.56 3.08 5.38 6.52 1.92 3.84 3.62 1.45
Shareholders Equity per Share
24.62 25.34 24.16 31.98 27.19 26.99 28.55 30.36 34.51 6.76
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
24.62 25.34 24.16 31.98 27.19 26.99 28.55 30.36 34.51 6.76
Free Cash Flow
242.10 212.30 230.80 91.10 35.50 262.50 73.50 124.00 91.30 86.13
Working Capital
535.20 495.00 372.00 427.60 409.30 244.70 127.40 239.00 260.22 175.23
Capital Expenditures
(32.20) (87.80) (63.00) (67.70) (51.60) 15.60 (56.00) (20.60) (29.60) (39.11)
Net Current Asset Value
(3,837.70) (3,574.20) (2,947.20) (2,820.20) (3,201.90) (3,295.10) (3,115.00) (2,629.80) (2,392.13) (1,618.33)
EV/EBIT
13.16 15.67 19.15 13.30 20.47 20.40 13.18 30.13 16.15 10.52
Capex to Sales
0.01 0.03 0.02 0.03 0.02 (0.01) 0.03 0.01 0.02 0.03
Net Profit Margin
(2.35%) (5.40%) (0.43%) (2.15%) (3.65%) (8.37%) (6.03%) (13.44%) (5.90%) 0.83%
Price to Operating Income
5.05 7.65 12.11 7.01 12.80 7.73 3.21 6.04 4.07 3.79
Other line items
Depreciation/Fixed assets
0.15 0.14 0.12 0.13 0.16 0.17 0.15 0.16 0.13 0.19
Cash ROIC
(12.43%) (11.53%) (11.24%) (12.28%) (10.24%) (6.63%) (9.72%) (7.10%) (6.89%) (4.30%)
Accounts Receivable Turnover
5.60 5.79 5.76 5.73 5.48 5.25 5.77 5.95 5.27 5.74
Accounts Payable Turnover
12.19 12.45 12.96 14.21 15.40 15.04 15.64 16.21 15.08 17.27
Inventory Turnover
27.50 28.96 28.59 29.65 29.51 28.83 31.38 30.82 27.50 30.21
Average Days of Payables
29.95 32.16 29.92 28.17 26.30 24.71 25.08 22.33 30.50 22.12
Days of Inventory on Hand
13.86 13.62 13.10 13.27 12.86 13.91 12.01 11.64 16.18 12.79
Average Receivables
590.65 537.75 476.35 443.25 406.20 354.55 317.25 297.81 254.31 199.71
Average Payables
208.70 190.25 161.70 138.25 112.55 98.45 90.00 84.01 67.24 47.55
Average Inventory
92.50 81.80 73.30 66.25 58.75 51.35 44.85 44.18 36.86 27.18
Average Assets
8,004.85 7,383.35 6,779.40 6,399.85 5,765.40 5,216.05 4,847.60 4,649.54 3,463.87 2,204.70
Average Common Equity
3,163.85 3,115.45 2,987.70 2,455.25 1,425.85 932.75 1,041.15 1,217.76 830.64 311.30

Fold the line items

Columns are period end dates